VSK Medical Limited, a cooperative joint venture between Vasomedical Inc. in the U.S. and PSK – Health in China, recently showcased their EECP/ECP devices at the Florida International Medical Exposition (FIME) which took place August 2 to August 4, 2016 in Miami Beach, Florida.
FIME, which draws approximately 20,000 attendees from across North, Central and South America, is one of the largest medical device shows for Mexico, Latin America and the Caribbean market. Over 1,500 companies from 38 countries also showcased their technology and products during the event.
VSK Medical Ltd. is a joint venture company formed by a cooperation agreement between Chongqing PSK-Health Sci-Tech Development Co., Ltd. (“PSK”) of Chongqing, China, a leading manufacturer of ECP therapy systems in China and Vasomedical Inc. in the United States, the world leader of EECP® Therapy, the gold standard in external counterpulsation. VSK combines resources of both companies to the marketing and clinical development of external counterpulsation therapy. This cooperative venture is intended to enable both companies to serve the global external counterpulsation market by offering their products through a more efficient and effective sales and service channel.
More information about these products is available on VSK’s website.